Shuang Yang

机构：Ruikang Affiliated Hospital of Guangxi Medical University · ORCID：0000-0002-9113-8456

发表论文 23 篇 · 总被引 141 次 · h-index 4

代表论文

• Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial (2022 · Journal of Experimental & Clinical Cancer Research · 被引 75)
• DNA Aptamer Selected against Esophageal Squamous Cell Carcinoma for Tissue Imaging and Targeted Therapy with Integrin β1 as a Molecular Target (2022 · Analytical Chemistry · 被引 20)
• A Genosensor Based on the Modification of a Microcantilever: A Review (2023 · Micromachines · 被引 18)
• First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report (2023 · World Journal of Surgical Oncology · 被引 6)
• The Influence of the Unit Junction on the Performance of a Repetitive Structure Micromixer (2022 · Micromachines · 被引 4)
• Meta-Analysis of the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced Gastric Cancer and Gastroesophageal Junction Cancer (2024 · Chemotherapy · 被引 3)